Effects of Elastic Tape on Pulmonary Rehabilitation of Patients with Chronic Obstructive Pulmonary Disease
ETReaCOPD
1 other identifier
interventional
42
1 country
1
Brief Summary
Evaluate the effect of the use of elastic tape in chest wall and abdomen in the physical capacity, psychosocial distress levels, quality of life and anxiety, and depression symptoms of individuals with moderate to very severe chronic obstructive pulmonary disease (COPD) undergoing pulmonary rehabilitation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable chronic-obstructive-pulmonary-disease
Started Oct 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 29, 2023
CompletedFirst Posted
Study publicly available on registry
July 11, 2023
CompletedStudy Start
First participant enrolled
October 26, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2025
CompletedDecember 9, 2024
December 1, 2024
1.4 years
June 29, 2023
December 4, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional Exercise Capacity: The total time reached in the Endurance Shuttle Walking Test (ESWT)
The patients will be instructed to walk in a 10-meter corridor limited by cones (with a distance of 9 meters between them), and the speed will be determined by a sound signal issued by cell phone, in this case, the speed will be determined using 85% of the maximum speed reached in the Incremental Shuttle Walking Test (ISWT) and will be constant throughout the test.
Change from baseline at 8 weeks of intervention.
Secondary Outcomes (3)
Clinical Control: COPD Assessment Test™ (CAT) is a specific questionnaire for COPD that assesses the impact of the symptoms of the disease
Change from baseline at 8 weeks of intervention.
Symptoms of Anxiety and Depression: Hospital Anxiety and Depression Scale (HADS): The questionnaire was developed to identify symptoms of anxiety and depressive mood.
Change from baseline at 8 weeks of intervention.
Health-related Quality of Life: was assessed by using the Chronic Respiratory Questionnaire (CRQ)
Change from baseline at 8 weeks of intervention.
Study Arms (2)
Elastic tape (ET)
EXPERIMENTALThe group that will participate in the 8 weeks pulmonary rehabilitation protocol using the elastic tape.
Sham (SH)
SHAM COMPARATORThe group that will participate in the pulmonary rehabilitation protocol using micropore tape.
Interventions
The elastic tape will be allocated in the chest wall and abdomen of individuals and will be used during the 8 weeks of rehabilitation protocol.
The micropore tape will be allocated in the chest wall and abdomen of individuals and will be used during the 8 weeks of rehabilitation protocol.
Eligibility Criteria
You may qualify if:
- Moderate to very severe COPD diagnosis according to Global Iniciative for Chronic Obstructive Lung Disease (GOLD) 2020
- Clinical stability (i.e., no exacerbations for at least 30 days)
- Male
- Non-obese (BMI ≤29.9 kg/m2)
- No musculoskeletal limitation
- Not included in a pulmonary rehabilitation program in the last 6 months.
- Do not perform home oxygen therapy
You may not qualify if:
- Present osteoarticular, cognitive, neurological, and/or cardiological dysfunctions that prevent physical training
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Hospital of São Paulo University medical school (HCFMUSP)
São Paulo, São Paulo, 05360-160, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Celso RF Carvalho
University of Sao Paulo General Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- Evaluations will be conducted blindly, that is, by an evaluator who will not be directly involved in the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 29, 2023
First Posted
July 11, 2023
Study Start
October 26, 2023
Primary Completion
April 1, 2025
Study Completion
May 1, 2025
Last Updated
December 9, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share